Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind phase II trial of QP002 Gel for post-thoracic surgery analgesia
CTR20230915Phase 2Active
- Sponsor
- ClearPoint Biotech
- Start
- Mar 2023
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of QP002 in postoperative pain, sponsored by ClearPoint Biotech. Started Mar 2023; status: active.
02
Drugs
QP002
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20230915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230915.